NO20002789L - Hydrofobisk-modifiserte proteinpreparater og fremgangsmater for fremstilling derav - Google Patents

Hydrofobisk-modifiserte proteinpreparater og fremgangsmater for fremstilling derav

Info

Publication number
NO20002789L
NO20002789L NO20002789A NO20002789A NO20002789L NO 20002789 L NO20002789 L NO 20002789L NO 20002789 A NO20002789 A NO 20002789A NO 20002789 A NO20002789 A NO 20002789A NO 20002789 L NO20002789 L NO 20002789L
Authority
NO
Norway
Prior art keywords
protein
methods
preparation
hydrophobically modified
modified protein
Prior art date
Application number
NO20002789A
Other languages
English (en)
Norwegian (no)
Other versions
NO20002789D0 (no
Inventor
R Blake Pepinsky
Darren P Baker
Dingyi Wen
Kevin P Williams
Ellen A Garber
Frederick R Taylor
Alphonse Galdes
Jeffrey Porter
Original Assignee
Curis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curis Inc filed Critical Curis Inc
Publication of NO20002789D0 publication Critical patent/NO20002789D0/no
Publication of NO20002789L publication Critical patent/NO20002789L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Graft Or Block Polymers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20002789A 1997-12-03 2000-05-31 Hydrofobisk-modifiserte proteinpreparater og fremgangsmater for fremstilling derav NO20002789L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6742397P 1997-12-03 1997-12-03
US7893598P 1998-03-20 1998-03-20
US8968598P 1998-06-17 1998-06-17
US9980098P 1998-09-10 1998-09-10
PCT/US1998/025676 WO1999028343A2 (fr) 1997-12-03 1998-12-03 Compositions a base de proteines modifiees sur le plan hydrophobe et procedes d'elaboration

Publications (2)

Publication Number Publication Date
NO20002789D0 NO20002789D0 (no) 2000-05-31
NO20002789L true NO20002789L (no) 2000-08-02

Family

ID=27490628

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002789A NO20002789L (no) 1997-12-03 2000-05-31 Hydrofobisk-modifiserte proteinpreparater og fremgangsmater for fremstilling derav

Country Status (26)

Country Link
US (1) US6444793B1 (fr)
EP (1) EP1036092B1 (fr)
JP (1) JP4289788B2 (fr)
KR (1) KR20010032753A (fr)
CN (1) CN1294595A (fr)
AT (1) ATE295372T1 (fr)
AU (1) AU757497B2 (fr)
BR (1) BR9815142A (fr)
CA (1) CA2309806A1 (fr)
CZ (1) CZ20002008A3 (fr)
DE (1) DE69830192T2 (fr)
DK (1) DK1036092T3 (fr)
EA (1) EA003739B1 (fr)
EE (1) EE200000308A (fr)
ES (1) ES2243018T3 (fr)
HK (1) HK1030953A1 (fr)
HU (1) HUP0100535A3 (fr)
IL (2) IL136137A0 (fr)
IS (1) IS2163B (fr)
MX (1) MXPA00005494A (fr)
NO (1) NO20002789L (fr)
NZ (1) NZ504752A (fr)
PL (1) PL197833B1 (fr)
PT (1) PT1036092E (fr)
TR (1) TR200001612T2 (fr)
WO (1) WO1999028343A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136230A0 (en) * 1997-11-28 2001-05-20 Roche Diagnostics Gmbh An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
EA003739B1 (ru) 1997-12-03 2003-08-28 Байоджен, Инк. Гидрофобно-модифицированные белки, способы их получения и их применение
US6897297B1 (en) 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
DK0953576T3 (da) * 1998-04-30 2006-03-20 Curis Inc Aktivt hedgehog-proteinkonjugat, fremgangsmåde til fremstilling heraf og anvendelse
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
CA2348773C (fr) * 1998-11-02 2010-04-13 Biogen, Inc. Antagonistes fonctionnels de l'activite hedgehog
IL143403A0 (en) * 1998-12-03 2002-04-21 Biogen Inc Methods and compositions for treating disorders involving excitotoxicity
EP1025861A1 (fr) * 1999-02-04 2000-08-09 Roche Diagnostics GmbH Compositions pharmaceutiques des Proteines Hedgehog rendues hydrophobes, et leur utilisation
EP1183271A1 (fr) * 1999-06-01 2002-03-06 Biogen, Inc. Conjugues polymeres de proteines hedgehog et leurs utilisations
WO2001034654A1 (fr) * 1999-11-05 2001-05-17 Biogen, Inc. Proteines de fusion herisson et leurs utilisations
AU2005203058C1 (en) * 1999-11-05 2009-07-02 Curis, Inc. Hedgehog fusion proteins and uses
AU2001255767A1 (en) * 2000-04-28 2001-11-12 Curis, Inc. Methods and reagents for tissue engineering of cartilage in vitro
WO2003089454A2 (fr) * 2002-04-19 2003-10-30 California Institute Of Technology Bibliotheque de molecules d'acides nucleiques et de peptides dont les peptides contiennent des residus d'acides amines non naturels, et methodes de production associee
CA2573720A1 (fr) 2004-07-14 2006-02-23 University Of Utah Research Foundation Compositions et utilisations liees a des netrines
EP1862180A4 (fr) * 2005-03-25 2010-09-15 Takeda Pharmaceutical Agent prophylactique et therapeutique contre le cancer
EP1951869A1 (fr) * 2005-11-11 2008-08-06 Proteogen Bio S.R.L. Procédé de conversion de protéines actives solubles dans l'eau en protéines actives hydrophobes, utilisation de celui-ci pour la préparation de couches monomoléculaires de protéines actives orientées et appareils comprenant celles-ci
US8273747B2 (en) 2006-11-02 2012-09-25 Curis, Inc. Small organic molecule regulators of cell proliferation
KR100876657B1 (ko) * 2007-10-15 2009-01-07 한국기계연구원 표면개질된 마이크로비드와 마이크로비드 어레이칩의제조방법과 마이크로비드 어레이칩을 이용한 질병특이항원의 확인방법
JP5576801B2 (ja) * 2008-02-21 2014-08-20 ダーマケア・ニューロサイエンス・インスティテュート Ｍｎｔｆペプチドの美容および皮膚科用製剤
WO2009108868A2 (fr) * 2008-02-27 2009-09-03 Radiomedix Inc. Dérivés hedgehog radiomarqués utilisés en imagerie et en thérapie
UA107571C2 (xx) * 2009-04-03 2015-01-26 Фармацевтична композиція
CN103665095A (zh) * 2012-09-11 2014-03-26 中国人民解放军军事医学科学院卫生学环境医学研究所 一种疏水性多肽修饰抗体的合成方法
CN106924752B (zh) * 2015-12-30 2021-11-09 北京大学 制备蛋白质-聚氨基酸偶联物的方法
CN108147990B (zh) * 2016-12-02 2023-01-24 上海中医药大学 一种膜锚定元件及其应用
AR113792A1 (es) 2017-10-25 2020-06-10 Janssen Pharmaceuticals Inc Composiciones de péptidos tau fosforilados y sus usos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
US5399347A (en) 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
US5409611A (en) * 1988-03-24 1995-04-25 Terrapin Technoogies, Inc. Method to identify analyte-binding ligands
US5130297A (en) 1988-06-23 1992-07-14 Anergen, Inc. Conjugates useful in ameliorating autoimmunity MHC-II-peptide
US5824315A (en) * 1993-10-25 1998-10-20 Anergen, Inc. Binding affinity of antigenic peptides for MHC molecules
US6281332B1 (en) * 1994-12-02 2001-08-28 The Johns Hopkins University School Of Medicine Hedgehog-derived polypeptides
US5869602A (en) * 1995-03-17 1999-02-09 Novo Nordisk A/S Peptide derivatives
JP2002503088A (ja) * 1996-10-07 2002-01-29 ザ ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン 新規ヘッジホッグ由来ポリペプチド
EA003739B1 (ru) 1997-12-03 2003-08-28 Байоджен, Инк. Гидрофобно-модифицированные белки, способы их получения и их применение

Also Published As

Publication number Publication date
EA003739B1 (ru) 2003-08-28
EE200000308A (et) 2001-10-15
KR20010032753A (ko) 2001-04-25
HUP0100535A2 (hu) 2001-06-28
IS2163B (is) 2006-11-15
PL341430A1 (en) 2001-04-09
IL136137A0 (en) 2001-05-20
CA2309806A1 (fr) 1999-06-10
HUP0100535A3 (en) 2003-09-29
NZ504752A (en) 2002-10-25
WO1999028343A3 (fr) 1999-08-12
DK1036092T3 (da) 2005-08-15
TR200001612T2 (tr) 2001-01-22
EA200000605A1 (ru) 2000-12-25
DE69830192T2 (de) 2006-01-12
PL197833B1 (pl) 2008-04-30
IL136137A (en) 2009-09-22
HK1030953A1 (en) 2001-05-25
EP1036092A2 (fr) 2000-09-20
DE69830192D1 (de) 2005-06-16
CZ20002008A3 (cs) 2001-11-14
WO1999028343A9 (fr) 1999-10-14
PT1036092E (pt) 2005-09-30
JP2001525336A (ja) 2001-12-11
BR9815142A (pt) 2000-10-10
MXPA00005494A (es) 2003-05-19
JP4289788B2 (ja) 2009-07-01
ATE295372T1 (de) 2005-05-15
EP1036092B1 (fr) 2005-05-11
CN1294595A (zh) 2001-05-09
NO20002789D0 (no) 2000-05-31
ES2243018T3 (es) 2005-11-16
US6444793B1 (en) 2002-09-03
AU1996699A (en) 1999-06-16
AU757497B2 (en) 2003-02-20
WO1999028343A2 (fr) 1999-06-10
IS5499A (is) 2000-05-15

Similar Documents

Publication Publication Date Title
NO20002789L (no) Hydrofobisk-modifiserte proteinpreparater og fremgangsmater for fremstilling derav
Hou et al. Peptidyl N, N-bis (2-mercaptoethyl)-amides as thioester precursors for native chemical ligation
DE60120713D1 (de) Funktionelles protein array
EP1067182A3 (fr) Proteine secretoire ou proteine de membrane
KR870001237A (ko) 혈액응고 억제작용을 갖는 폴리펩티드의 분리 및 제조 방법
DE60042235D1 (de) Prozess zur trennung von proteinen
IL115199A (en) Composition comprising a polynucleic acid molecule in a liposome and method using said composition
ATE500323T1 (de) Subtilisin-variante
BR9811675A (pt) Genes isolados para proteìna da membrana de célula dentrìtica
CY1105206T1 (el) Διαδικασια για την εκχυλιση και χρησιμοποιηση υγρου επωασης απο σολομο του ατλαντικου
WO2000000600A3 (fr) Vecteurs lentiviraux
KR880701778A (ko) 펩티드의 합성 및 분리를 위한 효소막법
JP2004535152A (ja) 細胞培養物に対する成長影響活性を有するカゼインペプチドフラグメント
ATE46703T1 (de) Regionspezifische determinanten fuer vitamin-k abhaengiges knochenprotein.
NO984491L (no) SCF-analogpreparater og fremgangsmÕte for fremstilling av disse
Gahmberg et al. Cell surface proteins: changes during cell growth and malignant transformation
WO1999028876A3 (fr) Compositions proteiniques modifiees de maniere hydrophobe et leurs procedes de fabrication
Ogishima et al. Partial amino acid sequences of two mitochondrial and two microsomal cytochrome P-450's from adrenal cortex
CY1105486T1 (el) Τροποποιημενες υδροφοβικα συνθεσεις πρωτεϊνων ακανθοχοιρου και μεθοδοι παρασκευης αυτων
WO2000032746A3 (fr) Acides nucleiques et polypeptides netrinoïdes et ependyminoïdes et leurs utilisations
WO2001025430A3 (fr) Nouvelles proteines membranaires humaines
Havran Chemical Modification of Chymotrypsinogen a With a Bifunctional Reagent
ECSP982583A (es) Genes aislados de proteinas de membranas de mamiferos reactivos relacionados
MX9700469A (es) Un substrato recombinante artificial (ragg 1) y agrecano natural para estudiar la actividad proteolitica de "agrecanasa" en sistemas de cultivos celulares.
RU94046405A (ru) Птг-соединения и содержащий их фармацевтический состав, способ получения желаемых полипептидов, нуклеотидная последовательность, бактериальный вектор экспрессии, бактериальные хозяйские клетки и составной белок

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application